Patients diagnosed with somatostatinoma should be screened for other components of MEN-1 by either serum calcium level (parathyroid hormone and ionized calcium level can be added to enhance sensitivity and specificity) or DNA-based genetic testing. The gene discussed is PTH; the disease is multiple endocrine neoplasia type 1.